The Zhitong Finance App learned that IMAX China (01970) rebounded moderately, rising about 6% at the beginning of the session. According to Daimo's latest report, the company's 23-year performance is expected to rebound strongly. Revenue is expected to increase 29% year over year, and net profit is expected to rise 108% year over year. The target price was raised to HK$10.5. As of press release, IMAX China rose 5.83% to HK$10.90, with a turnover of HK$10 million.

On February 3, Morgan Stanley released an updated report saying that although IMAX China's 22H2 box office revenue is expected to drop 17% year over year, it is superior to the industry's overall decline of 40%, while the market share is estimated to have increased to about 5%. Due to factors such as industry recovery, it is expected that the company's performance will rebound strongly this year. Revenue is expected to increase 29% year over year, and net profit may rise 108% year over year. The target price was raised to HK$10.5, and the rating remained “in sync with the market”. Earlier, IMAX China announced that as of January 27, IMAX had grossed 231 million yuan during the six-day Lunar New Year holiday, setting a record for the highest Spring Festival box office in history.